25G＋微创玻璃体切割治疗Terson综合征疗效分析  

The efficacy of 25G＋ vitrectomy system for treatment of Terson syndrome

作　　者：杨新怀[1] 全婵娟[1] 王敬伟[1] 王虎[1] 覃旭方[1] 

机构地区：[1]南方医科大学附属小榄医院眼科,广东中山市528415

出　　处：《中国实用眼科杂志》2016年第6期629-631,共3页Chinese Journal of Practical Ophthalmology

摘　　要：目的探讨和评价25G＋微创玻璃体切割手术治疗Terson综合征的有效性和安全性。方法回顾分析2012年11月至2014年8月Terson综合征患者4例（7只眼），行25G＋玻璃体切割术，观察术中手术时间及出血部位，术后l天、1周、1月、3月，6月裸眼视力、最佳矫正视力、切口愈合情况、眼内压、晶状体混浊、玻璃体腔清晰度、视网膜在位、切口处玻璃体残留、黄斑前膜。结果所有患者术后视力较术前明显提高，手术切口愈合良好，晶状体较术前混浊程度无增加，视网膜在位，无明显玻璃体残留，无眼内压下降等并发症发生。结论25G＋微创玻璃体切割手术治疗Terson综合征患者的玻璃体积血快速、安全、有效。Objective To evaluate the efficacy and safety of 25G＋ micro-invasive vitrectomy for treatment of Terson syndrome. Methods From November 2012 to August 2014, 4 patients （7 eyes） with Terson syndrome were analyzed retrospectively. The patients received 25G＋ vitrectomy. The bleeding part, operating time, UCVA, BSCVA, wound healing, IOP, lens and vitreous opacification, retina reattachment, vitreous residual, macular epiretinal membrane were detected 1 day,1 week, 1 month, and 3-6months after the operation. Results The improvement of visual acuity was found in all patients, and the incision was healed well, retina was flat, no vitreous residual, the intraocular pressure was stable. Conclusions It is effective and safe that 25G＋ vitrectomy for treatment of Terson syndrome.

关 键 词：微创 TERSON综合征 玻璃体切割术 

分 类 号：R743.35[医药卫生—神经病学与精神病学]